Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Genes|November 3, 2020
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European PopulationsAnca Liliana Cismaru, Deborah Rudin, Luisa Ibañez, et al.
Clinical Chemistry|February 3, 2009
Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2Tohru Aomori, Koujirou Yamamoto, Atsuko Oguchi-Katayama, et al.
Circulation. Cardiovascular Genetics|August 10, 2017
<i>CKM</i> Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With MyalgiaMoneeza Kalhan Siddiqui, Abirami Veluchamy, Cyrielle Maroteau, et al.
Pharmacogenomics|December 23, 2010
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and PharmacogenomicsLaurent Becquemont, Ana Alfirevic, Ursula Amstutz, et al.
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Pharmacogenomics|August 13, 2015
Genome-wide association study of warfarin maintenance dose in a Brazilian sampleEsteban J Parra, Mariana R Botton, Jamila A Perini, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
Pharmacogenomics|September 13, 2012
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsTalitha I Verhoef, William K Redekop, Rianne Mf van Schie, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Genes|November 3, 2020
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European PopulationsAnca Liliana Cismaru, Deborah Rudin, Luisa Ibañez, et al.
Clinical Chemistry|February 3, 2009
Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2Tohru Aomori, Koujirou Yamamoto, Atsuko Oguchi-Katayama, et al.
Circulation. Cardiovascular Genetics|August 10, 2017
<i>CKM</i> Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With MyalgiaMoneeza Kalhan Siddiqui, Abirami Veluchamy, Cyrielle Maroteau, et al.
Pharmacogenomics|December 23, 2010
Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and PharmacogenomicsLaurent Becquemont, Ana Alfirevic, Ursula Amstutz, et al.
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Pharmacogenomics|August 13, 2015
Genome-wide association study of warfarin maintenance dose in a Brazilian sampleEsteban J Parra, Mariana R Botton, Jamila A Perini, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
Pharmacogenomics|September 13, 2012
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsTalitha I Verhoef, William K Redekop, Rianne Mf van Schie, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Pageof 10